miRNA signature associated with outcome of gastric cancer patients following chemotherapy. - Wikidata - awgldk - TriplyDB

miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

http://www.wikidata.org/entity/Q34082270

about

Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer Molecular classification and prediction in gastric cancer Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review Clinical application of microRNA in gastric cancer in Eastern Asian area Systems biology of cisplatin resistance: past, present and future Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer.A novel microRNA signature predicts survival in stomach adenocarcinoma.Role of microRNA-1 in human cancer and its therapeutic potentials.Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2 A systematic review of microRNA expression profiling studies in human gastric cancer.Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection.MicroRNAs: short non-coding players in cancer chemoresistance.Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type.miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer.Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells The role of microRNAs in cancers of the upper gastrointestinal tract.The effect of microRNAs in the regulation of human CYP3A4: a systematic study using a mathematical model Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer MicroRNA as a novel drug target for cancer therapy.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Caspase-9 as a therapeutic target for treating cancer.Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.Novel biomarkers for the identification and targeted therapy of gastric cancer.The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.

P2860

Q26741242-568C0B63-E161-44EB-BE14-B26491C65783 Q26744362-251960C3-3048-4AFA-B379-C22A65180E2C Q26752006-C13CCE14-F4C2-4770-A660-0F18DA426536 Q26783806-E6B0D75B-9CC8-4A8A-BE36-95BA80E4C30A Q26785539-B982AFD7-04FF-4970-8354-23AF7D009264 Q26829583-0EE2F2C0-7309-405C-893A-F1DF79BB1A0C Q26863585-5ED06304-5C01-4BB7-A78F-161D941434F1 Q28067449-8213E547-F26C-4347-86C1-C789D7867F35 Q33701796-DF07852D-CCAC-4DF9-B3D4-0736DE7505AB Q33709612-F9DCD92E-D1FA-41FA-A4E8-9AC33770D550 Q33737275-F8A53FE9-9CBC-4D5C-8E97-3C15F723AC06 Q33913929-457F31F9-95F2-414A-BF86-64ACF38CD61E Q34194661-961BA19C-322E-420C-9162-893331BF0941 Q34326553-5040562D-50EA-4F5D-9E80-63020565559D Q34733320-973509FE-794A-4175-A974-622A712BD14F Q35000434-396D55EE-5309-4A3A-AC7F-4FDE0DB7C478 Q35151777-9CED71FF-81EB-4B62-9CA9-2665F78588DC Q35673637-10E51366-5FAC-4B4C-9D7A-82E0D19057A4 Q35690791-FE888629-8523-4FF6-A1DD-10E2443AE4C3 Q36278121-0D822E6A-BF4A-4D98-8C12-1C7BA97FBB56 Q36494718-3CFD8643-A47E-4936-8AAD-5A3676C72769 Q36502791-A5E71CF0-BE2C-494D-A0C1-560880EFBA2D Q36525110-ED24612A-20C1-4984-B07F-3FE9692DD49F Q36585797-2F540883-0793-4656-9B23-37CB2A3AAAFC Q36729463-3A25E2F8-AC1C-4B35-BBD4-9D1EBD5E232D Q36765105-F0C6FCDE-C454-4962-B3EB-0EB54565E9D5 Q37003364-8D51F080-4D6F-4051-ADA7-AC6A53853E95 Q37046660-242C6AD3-F952-43C1-B339-160D6E58086C Q37109827-E48A2BBC-2F19-4B73-BE8B-65B6DB92EAEC Q37374880-C036E5F1-DF5D-47F9-B98E-AC5FF4B0A06C Q37617645-33B42947-D2F2-4CCC-90D8-7521B966EAE8 Q37684021-03057021-5921-4F2D-9B9E-A9C40A387C01 Q37994747-27EB224F-42B2-464A-AA7A-D96C025BF446 Q38202662-0CC9CEBB-EF39-4547-AC94-24D144FF202B Q38254387-840E1BB0-690F-4C5B-B563-7EDD2ED3A874 Q38321812-4AEEAE13-2B9A-460D-B975-B31B0115A464 Q38379668-41DA99BF-A0C8-4D4D-BB2B-56F0C9E435E3 Q38556435-71F07139-AFF2-4E55-8FE7-AD934E5B7F65 Q38710597-6F0D9EC5-0859-4959-9B5B-B7916009AFA7 Q38792595-AA3C9A05-4B99-4EE0-B02D-A013B4A17ED4

P2860

miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

http://www.wikidata.org/entity/Q34082270

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

miRNA signature associated wit ...... tients following chemotherapy.

@ast

miRNA signature associated wit ...... tients following chemotherapy.

@en

miRNA signature associated wit ...... tients following chemotherapy.

@nl

type

label

miRNA signature associated wit ...... tients following chemotherapy.

@ast

miRNA signature associated wit ...... tients following chemotherapy.

@en

miRNA signature associated wit ...... tients following chemotherapy.

@nl

prefLabel

miRNA signature associated wit ...... tients following chemotherapy.

@ast

miRNA signature associated wit ...... tients following chemotherapy.

@en

miRNA signature associated wit ...... tients following chemotherapy.

@nl

P1433

Q34082270-634E8F17-40B1-42CB-BBA8-0EA9CF268F07

P1476

Q34082270-B84DB140-B43F-4EF5-9274-BD4B6F1FC99C

P2093

Q34082270-147A34E0-7107-42BA-994B-21B2AA258667

Q34082270-3222C04A-D8DC-47FE-B531-BF95D246B10A

Q34082270-64FAD87E-32F2-4427-87CB-D135F17B58CF

Q34082270-A765D78D-B4B4-42A9-84AB-C290593E9324

Q34082270-AFE942B8-6C89-4C98-A2F9-8F7DE5BAD530

Q34082270-D9867D62-748F-48A3-933D-FA76D9921EC7

Q34082270-DA7353F8-648D-419C-B3F0-1FC180CA497A

Q34082270-E11DDD4A-AA97-472B-8F97-AFED3A832080

Q34082270-FC0EC85C-DDC9-4411-919C-B4CEBD3EF83E

P2860

Q34082270-0557B405-85C6-47EA-8B99-8B177D9B2D12

Q34082270-05D67969-0125-48E2-B032-271DFA706171

Q34082270-11A13725-82C6-40C0-8F06-8AB255A793FB

Q34082270-26501611-2457-438B-9188-DA454453A836

Q34082270-3078A373-EDFB-458D-8099-36C8F751612A

Q34082270-311E1F0F-D7DD-4319-8885-3137ABDDB26F

Q34082270-3310A36F-5903-4A5A-8E83-DCD95BEA6495

Q34082270-382D7CA5-98A6-4435-AC72-31CE3E4A52E3

Q34082270-4A0944E0-9099-48EF-B49C-FC90D84CB57A

Q34082270-501F3ED9-E566-4543-99E0-9723B461BD2E

P2888

Q34082270-5C5560E2-0281-4A1E-A37F-6941D1649981

P304

Q34082270-51589AEE-1F67-4FCB-9C7A-FDF5E8B32972

P31

Q34082270-DA0790A0-C1EB-45AD-8EEC-6596D845223A

P356

Q34082270-062A69AA-F500-4B4B-BC43-0EFB18B1A8A3

P478

Q34082270-99F30649-6448-4980-9A81-6547D3138C9D

P577

Q34082270-902105C3-C88F-49D9-BAAE-E1F0A6202B7A

P5875

Q34082270-48DE9CEC-B9B8-4DE0-A469-9E39F9611EC5

P6179

Q34082270-BB995EB8-5E63-47F9-9AAE-2AAECE1CE24F

P698

Q34082270-8AB33071-6883-4FA4-84F4-3BCC47158CA7

P921

Q34082270-3FA110CC-EB16-4064-AED9-4732240B8239

Q34082270-768A2F7B-A8D4-4813-87DF-E98A7163648B

P932

Q34082270-9BA9F7A0-8D12-4C82-BAE0-E6753580D0C0

P356

P1433

BMC Medical Genomics

P1476

miRNA signature associated wit ...... tients following chemotherapy.

@en

P2093

Chang Hee Kim

http://www.w3.org/2001/XMLSchema#string

David J Munroe

http://www.w3.org/2001/XMLSchema#string

Eunbyul T Lee

http://www.w3.org/2001/XMLSchema#string

Hark K Kim

http://www.w3.org/2001/XMLSchema#string

Il J Choi

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Green

http://www.w3.org/2001/XMLSchema#string

Joseph Kim

http://www.w3.org/2001/XMLSchema#string

Olga Aprelikova

http://www.w3.org/2001/XMLSchema#string

R Luke Rettig

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

Semi-supervised methods to predict patient survival from gene expression data

MicroRNAs: genomics, biogenesis, mechanism, and function

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The miR-34 family in cancer and apoptosis

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

MicroRNAs in Cancer

P2888

P304

79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-8794-4-79

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51824660

http://www.w3.org/2001/XMLSchema#string

P6179

1016284798

http://www.w3.org/2001/XMLSchema#string

P698

22112324

http://www.w3.org/2001/XMLSchema#string

P921

P932

3287139

http://www.w3.org/2001/XMLSchema#string